Autopsy report · NCT03269383

Study to Evaluate the Effectiveness of SGB in Preventing Post-op Atrial Fibrillation

“Lack of funding and other logistical issues”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

Christopher Connors, MD

Sponsor type

University, hospital or other

Conditions

Atrial Fibrillation

Interventions

Bupivacaine; Saline

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Ultra-low Dose Subcutaneous IL-2 in Renal Transplantation
  “lack of funding/resources” (86% match in meaning)
• Systematic Work Environment Model Incorporating Web-based Neck-specific Exercise for Dental Staff With Neck Pain
  “Lack of fundings” (85% match in meaning)
• Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer
  “lack of funding” (85% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.